This helps eligible businesses power positive change by offering specialist support such as mentoring, masterclasses, networking, investment and more. This support was developed with deep tech chemistry and its unique challenges at its heart.
Following the Emerging Technologies Competition, our 68 winners have gone on to raise a combined total of over £200M in equity investment and grant funding, they’ve expanded overseas, secured commercial contracts, collectively doubled their number of employees and conducted clinical and industrial scale trials. This cohort is a powerhouse for change in the world and we’re inspired by the way they are reshaping the way we live and improving our society and well-being.
Find out more about this year’s winners
This year’s finalists have turned medical waste into chemical feedstocks, produced reusable menstrual products to improve quality of life in developing countries, degraded PFAS with sonolysis, and much more.
Find out more about the vast breadth of technologies represented at this year’s final and how they are creating impact.
This year’s deserving winners have now been announced:
Enabling Technologies: Imperial College London
Imperial College London have innovated solid-phase peptide synthesis to allow the synthesis of multiple peptide fragments on a single bead. This improves on the classic approach of making one fragment per bead, which boosts the productivity of existing peptide analogues.
Energy: University of Cambridge
Hydrogen is a promising carbon-free fuel that currently relies on fossil methane or expensive electrolysers. H2Upgrade converts zero-value industrial wastes into high-purity hydrogen and enables waste-producing companies to become hydrogen producers and consumers.
Environment: ThioTech Ltd
Utilising low cost and abundant waste product, elemental sulfur, and sustainably sourced chemicals, their next generation absorbents remove toxic metal residues from water, oil, and gas.
Health: Ignota Labs
Over half of all small molecular projects fail due to safety issues, causing a loss of up to £100BN and 1,500 potentially life-changing drugs every year. Ignota Labs have developed a novel AI platform to understand the root of these problems and understand drug interactions with the body and their biological impact, and thus enable drug failure turnaround.
Congratulations to all of these incredible businesses and their pitches, we’re excited to follow your journeys and see how you will turn your ideas into real world impact, and we can’t wait to see what new technologies will emerge next year.